Oral Antiplatelet Agents and Bleeding Risk in Relation to Major Cardiovascular Surgery

Publisher： Bentham Science Publishers

E-ISSN： 2212-3911|1|3|281-287

ISSN： 1574-8863

Source： Current Drug Safety, Vol.1, Iss.3, 2006-01, pp. : 281-287

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Antiplatelet agents in cardiovascular disease

By Lopes Renato  

Journal of Thrombosis and Thrombolysis, Vol. 31, Iss. 3, 2011-04 ,pp. : 306-309

Springer Publishing Company

Access to resources Recommend Favorite

Reversal Agents for Oral Antiplatelet and Anticoagulant Treatment During Bleeding Events: Current Strategies

By  

Current Pharmaceutical Design, Vol. 23, Iss. 9, 2017-04 ,pp. : 1406-1423

Bentham Science Publishers

Access to resources Recommend Favorite

Response to Dual Antiplatelet Therapy Does Not Impact Bleeding Risks in Patients Undergoing Oral Surgery after Acute Coronary Syndromes

By  

Cardiology, Vol. 132, Iss. 2, 2015-07 ,pp. : 119-123

Karger

Access to resources Recommend Favorite

Plasma Levels of Free Thyroxine and Risk of Major Bleeding in Bariatric Surgery

By  

European Thyroid Journal, Vol. 5, Iss. 2, 2016-06 ,pp. : 139-144

Karger

Access to resources Recommend Favorite

Risk factors for peptic ulcer bleeding in terms of Helicobacter pylori, NSAIDs, and antiplatelet agents

By Kang Jung Mook   Kim Nayoung   Lee Byoung Hwan   Park Hyun Kyung   Jo Hyun Jin   Shin Cheol Min   Lee Sang Hyub   Park Young Soo   Hwang Jin Hyeok   Kim Jin Wook   Jeong Sook-Hyang   Lee Dong Ho   Jung Hyun Chae   Song In Sung  

Scandinavian Journal of Gastroenterology, Vol. 46, Iss. 11, 2011-11 ,pp. : 1295-1301

Informa Healthcare

Access to resources Recommend Favorite